A novel study uncovers how a subtle chemical tweak transforms the naturally occurring phytotoxin into a powerful molecular ...
The cell-free protein synthesis (CFPS) market is set to reach USD 308.9 million by 2030, growing at a CAGR of 7.3%. Key growth drivers include rising demand for rapid protein production, adoption of ...
A novel study uncovers how a subtle chemical tweak transforms the naturally occurring phytotoxin into a powerful molecular glue, 12-deoxyfusicoccin (12-dFC), that locks 14-3-3 proteins onto the ...
Ginkgo Bioworks (DNA) stock is in focus as the company as part of a collaboration with Microsoft (MSFT)-backed OpenAI cuts protein synthesis costs. Read more here.
Preprint describes how GPT-5-driven autonomous lab significantly reduced reaction costs in cell-free protein synthesis Ginkgo ...
It had been thought that AI would play a big part in digital-only domains like math and coding, but cleverly connecting these ...
Ginkgo Bioworks says a new AI collaboration with OpenAI is already paying off, cutting the cost of protein production in the lab by a mea ...
Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
A research collaboration has found that besides regulating the fusion of mitochondria, Mitofusin 2 also ensures protein quality control. This discovery could open up new routes to treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results